Digital pathology is a field of pathology that
emphases on data management based on information generated from digitized
specimen slides. It incorporates the management, acquisition, sharing &
interpretation of pathology information including data and slides in a digital
environment. Digital slides are formed when glass slides are captured through a
scanning device, to provide a high-resolution digital image that can be
observed on a computer screen or mobile device.
According to study, “Global
Digital Telepathology Market Status (2015-2019) and Forecast
(2020-2024) by Region, Product Type & End-Use” some companies operating in
the global digital telepathology market are Olympus Corporation, Ventana
Medical Systems, Inc., Koninklijke Philips N.V., Diagnostic Instruments Inc.,
Mikroscan Technologies, Inc., Leica Biosystems Nussloch GmbH, GE Healthcare,
eVisit Telemedicine Solution, Teleconsult Europe, Unilabs. Key companies are
focusing on emergent digital pathology scanners with enhanced resolution, high
magnification, high throughput, and high-end microscopes using automated
scanning, all of which are anticipated to drive the market growth during the
forecast period.
Based on type, digital telepathology market is
segmented into veterinary pathology and human pathology. Human pathology
segment holds major share in market owing to rise in number of cancer research
activities and growth in collaborations between universities, academic research
institutes, and pathology laboratories.
Based on product type, market is segmented into scanners, communication
systems, software, and storage system. The software segment is anticipated to
witness the highest growth rate due to rise in availability of analytical,
user-friendly, and advanced functions for pathology diagnosis during the
forecast period. Based on technology, market is segmented into telepathology
and whole side imaging technology. Based on application, market is segmented
into drug discovery, teleconsultation, training & education, disease
diagnosis (cancer cell detection) and others. The teleconsultation segment is
anticipated to exhibit substantial growth rate as a result of increase in need
for quality & fast diagnosis and shortage of pathologists in developing
countries during the forecast period. In addition, based on end-user, market is
segmented into hospitals, pharmaceutical & biotech companies, diagnostic
centers & pathology clinics, academic institutes and research organizations
etc.
The digital telepathology market is driven by
rise in prevalence of cancer, followed by ease of consultation enabled by
digital pathology, growth in adoption of digital pathology to enhance lab
efficiency, increase in initiatives by governments & industry players and
growth in applications of digital pathology in drug development or companion
diagnostics. However, lack of standard guidelines and high cost of digital
pathology systems may impact the market. Moreover, integration of digital
pathology systems and Laboratory Information Systems (LIS) and introduction of
affordable scanners for private pathology practices are key opportunities for
market. Furthermore, rise in digitalization and information technology across
the globe is a major trend for market.
Based on geography, the North-American region
holds major share in digital telepathology market owing to rise in prevalence
of chronic diseases and increase in government initiatives in the region.
Whereas, the European and Asian-Pacific regions are exhibit higher growth rate
due to growth in healthcare expenditure and increase in awareness related to
digital pathology systems over the forecast period. In upcoming years, it is
projected that future of the market will be bright on account of rise in
awareness pertaining to the benefits of using Computer-Aided Diagnostics (CAD)
and growth in fiscal stability during the forecast period.
For More Information, Click on the
Link Below:-
Related
Reports:-
Contact Us:
Ken Research
Ankur Gupta, Head Marketing &
Communications
+91
9015378249
No comments:
Post a Comment